PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS
TECHNOLOGY
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS WHAT WE DO TECHNOLOGY INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
Completed inclusion of patients in the phase I/II extension study of Amphinex®
NewsadminMay 30, 2012
Status of the phase II study of Amphinex® in head and neck cancer patients
NewsadminMarch 30, 2012
Received CE marking for the PCI 652nm medical laser
NewsadminJanuary 13, 2012

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED